| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |